TRPM8 and posterior cortical atrophy: Indeed, TRPM8 channel expression changes during PCa progression, revealing an upregulation in the early stages of both benign prostate hyperplasia and malignant prostate carcinoma followed by downregulation and silencing during late metastatic stages of PCa after hormonal therapy against androgens [23,24,25].